Skip to main content
OpenTrials
Completed

NCT Number: NCT00644774

A Pediatric Taste Test Study of Omnicef Versus Zithromax Antibiotic Suspension Medications

To compare the taste and smell acceptability of cefdinir (Omnicef) antibiotic suspension and azithromycin (Zithromax) antibiotic suspension following a single dose of each medication.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Age range

4 year–8 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Phase 4

Primary location

Scottsdale, Arizona, United States

Loading trial locations.

About this study

The Primary Purpose for the study is "Other". Per ClinicalTrias.gov, more information regarding the primary purpose is described here; this study is a pediatric taste test.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Female or male child age 4 through 8 years in good general health.
  • Minimum weight of 16.3 kg (36 lb).
  • Willing to comply with appropriate instructions provided to complete the study.
  • Written informed consent from parent/legal guardian.

Exclusion criteria

  • Current medical condition, that in the opinion of the Investigator or designee, may interfere with the ability to discriminate taste (e.g., common cold, sinus infection, bronchial infection, etc.).
  • History of allergic reaction to cefdinir, azithromycin, prescription (e.g. penicillins or cephalosporins) and/or OTC medications, and/or food products.
  • History of significant medical condition (e.g., GI disorders, hematological or bleeding disorders, renal or hepatic diseases).
  • Use of any oral medication, vitamins or herbal supplements within 6 hours prior to tasting.
  • Temperature > than 99.2°F. Participation in a clinical or marketing research study within the past 3 months.
  • Sibling of another subject on the study, or living in the same household as another subject that has participated in a clinical or marketing research study within the past 3 months.
  • Family member or close friend employed by an advertising agency, market research company, and/or a company that processes or manufacturers medical or health care products.

Treatment and study plan

cefdinir (Omnicef)

Drug

2.5 ml of strawberry cream flavored oral suspension 125 mg/5 ml

Other names: ABT-198, Omnicef, cefdinir

Azithromycin

Drug

2.5 ml of cherry flavored oral suspension 100 mg/5 ml

Other names: Zithromax

Primary outcomes

  1. Taste and smell acceptance and preference

    Time frame: 2 hours

Secondary outcomes

  1. Adverse events assessment

    Time frame: 72 hours with follow-up to a satisfactory conclusion

  2. Concomitant Medications

    Time frame: 72 hours

  3. Vital signs

    Time frame: 2 hours

  4. Any clinically abnormal observations

    Time frame: 2 hours with follow-up to a satisfactory conclusion

Sponsors and collaborators

Lead sponsor

Abbott

Industry

Registry information

Official study title

A Comparative, Multi-Center, Pediatric Taste Test Study of Omnicef Versus Zithromax Antibiotic Suspension Medications

Important dates

Study start
2003
Primary completion
2003
First posted
Mar 27, 2008
Registry last updated
Mar 27, 2008

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.